Comparison between Franchiseindia.com IPO and GNH India Pharmaceuticals IPO.
Franchiseindia.com IPO is a SME Bookbuilding IPO proposed to list at NSE SME while GNH India Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Franchiseindia.com IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Corporate Makers Capital Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Franchiseindia.com IPO is up to ₹0.00 Cr whereas the issue size of the GNH India Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Franchiseindia.com IPO is and of GNH India Pharmaceuticals IPO is .
| Franchiseindia.com IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 24,60,000 shares | 37,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 24,60,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Franchiseindia.com IPO opens on , while GNH India Pharmaceuticals IPO opens on . The closing date of Franchiseindia.com IPO and GNH India Pharmaceuticals IPO is , and , respectively.
Franchiseindia.com IPO P/E ratio is , as compared to GNH India Pharmaceuticals IPO P/E ratio of .
| Franchiseindia.com IPO | GNH India Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 97.27 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 118.81% | 22.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 156.35% | 21.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 118.81% | 16.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Franchiseindia.com IPO Retail Individual Investors (RII) are offered while in GNH India Pharmaceuticals IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Franchiseindia.com IPO and in GNH India Pharmaceuticals IPO.
Franchiseindia.com IPO subscribed in total, whereas GNH India Pharmaceuticals IPO subscribed .
